The Effects of Prednisone on HIV Levels and the Immune System
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2011-02-23
- Target Recruit Count
- 118
- Registration Number
- NCT00000921
- Locations
- πΊπΈ
Univ of Southern California / LA County USC Med Ctr, Los Angeles, California, United States
πΊπΈMount Sinai Med Ctr, New York, New York, United States
πΊπΈNorthwestern Univ Med School, Chicago, Illinois, United States
A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients
- Conditions
- Pneumonia, Pneumocystis CariniiHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 2500
- Registration Number
- NCT00000748
- Locations
- πΊπΈ
Community Consortium of San Francisco, San Francisco, California, United States
πΊπΈAIDS Research Consortium of Atlanta, Atlanta, Georgia, United States
πΊπΈAIDS Research Alliance - Chicago, Chicago, Illinois, United States
Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs
- Conditions
- HIV Infections
- Interventions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-05
- Target Recruit Count
- 43
- Registration Number
- NCT00016718
- Locations
- π΅π·
Univ. of Puerto Rico Ped. HIV/AIDS Research Program CRS, San Juan, Puerto Rico
πΊπΈChicago Children's CRS, Chicago, Illinois, United States
πΊπΈChildren's Hosp. of Boston NICHD CRS, Boston, Massachusetts, United States
A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients
- Conditions
- HIV InfectionsPneumonia, Pneumocystis Carinii
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 600
- Registration Number
- NCT00000991
- Locations
- πΊπΈ
Chicago Children's CRS, Chicago, Illinois, United States
πΊπΈJohns Hopkins Adult AIDS CRS, Baltimore, Maryland, United States
πΊπΈCase CRS, Cleveland, Ohio, United States
A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 240
- Registration Number
- NCT00000994
- Locations
- πΊπΈ
Los Angeles County - USC Med Ctr, Los Angeles, California, United States
πΊπΈUCLA CARE Ctr, Los Angeles, California, United States
πΊπΈUniv of California / San Diego Treatment Ctr, San Diego, California, United States
A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women
- Conditions
- HIV InfectionsCervix, Dysplasia
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 158
- Registration Number
- NCT00000758
- Locations
- πΊπΈ
Usc La Nichd Crs, Los Angeles, California, United States
πΊπΈUniv. of Miami AIDS CRS, Miami, Florida, United States
πΊπΈBeth Israel Deaconess Med. Ctr., ACTG CRS, Boston, Massachusetts, United States
A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia
- Conditions
- HIV InfectionsPneumonia, Pneumocystis Carinii
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 20
- Registration Number
- NCT00001003
- Locations
- πΊπΈ
SUNY - Stony Brook, Stony Brook, New York, United States
A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 25
- Registration Number
- NCT00000956
- Locations
- πΊπΈ
St. Louis Univ. School of Medicine AVEG, Saint Louis, Missouri, United States
πΊπΈJHU AVEG, Pittsburgh, Pennsylvania, United States
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of MN Recombinant Soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 110
- Registration Number
- NCT00001052
- Locations
- πΊπΈ
JHU AVEG, Pittsburgh, Pennsylvania, United States
πΊπΈUW - Seattle AVEG, Seattle, Washington, United States
πΊπΈVanderbilt Univ. Hosp. AVEG, Nashville, Tennessee, United States
The Safety of Different Dose Levels of Zidovudine in HIV-Infected Children
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 400
- Registration Number
- NCT00000983
- Locations
- πΊπΈ
UCLA Med Ctr / Pediatric, Los Angeles, California, United States
πΊπΈChildren's Hosp of Los Angeles/UCLA Med Ctr, Los Angeles, California, United States
πΊπΈCedars Sinai / UCLA Med Ctr, Los Angeles, California, United States